Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Status
RECRUITING
Phase
Age
≥ 18 Years
Enrollments
150Conditions
Prostate CarcinomaSummary
This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.
Detailed Description
PRIMARY OBJECTIVE:
I. To create an annotated biorepository with prospectively collected blood and urine samples from men with advanced prostate cancer.
OUTLINE: This is an observational study.
Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.
Locations
2 locations Found with status Recruiting
Status
- RECRUITING
Contact Person
- Cheryl Kefauver, RN
- 323-865-0459
- [email protected]
Principal Investigator
- Amir Goldkorn, MD
Status
- RECRUITING
Contact Person
- Cheryl Kefauver, RN
- 323-865-0459
- [email protected]
Principal Investigator
- Amir Goldkorn, MD
Eligibility Criteria
Inclusion Criteria:
* * Men of all racial and ethnic groups 18 years of age or older
* Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
* Prior participation on clinical trials is allowed
Exclusion Criteria:
* * Inability to give informed consent
Study Plan
Observational
Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.
OTHER:
Non-Interventional StudyDescription:
Non-interventional study
Outcome Measures
Primary Outcome Measures
Collection of biological specimens and clinical data for future research related to prostate cancer.
Timeline
Last Updated
October 10, 2024Start Date
October 4, 2023Today
February 5, 2025Completion Date ( Estimated )
February 21, 2027
Sponsors of this trial
Lead Sponsor
University of Southern CaliforniaCollaborating Sponsors
National Cancer Institute (NCI)
RECRUITING 
21 - 64 Years